Related Experiment Video
Updated: Jun 6, 2025

10:22
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
8.8K
Multiomic interrogation of an endomembrane disrupting antimalarial
Sophie L Collier1, Stuart A Ralph1
1Department of Biochemistry & Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Australia.
Trends in Parasitology
|November 21, 2024
Summary
Researchers explored natural products as potential antimalarial drugs. They addressed challenges like complex synthesis and unclear mechanisms of action for isocyanoterpenes, offering solutions for drug development.
Area of Science:
- Natural product chemistry
- Medicinal chemistry
- Parasitology
Background:
- Natural products offer diverse chemical structures for drug discovery.
- Developing natural products into pharmaceuticals faces hurdles like complex synthesis and resistance.
- The kalihinol family of isocyanoterpenes presents potential antimalarial properties.
Purpose of the Study:
- To investigate and propose solutions for the challenges in adapting natural products as antimalarials.
- To address the cryptic mechanisms of action and resistance associated with natural product antimalarials.
- To explore feasible synthesis routes for kalihinol-based compounds.
Main Methods:
- Literature review and analysis of existing research on isocyanoterpenes.
- Chemical synthesis pathway exploration.
- Mechanism of action and resistance studies (proposed).
Main Results:
- Identified key challenges in natural product antimalarial development.
- Proposed strategies to overcome synthesis complexity and cost.
- Suggested approaches to elucidate mechanisms of action and resistance.
Conclusions:
- The kalihinol family of isocyanoterpenes shows promise as a scaffold for novel antimalarial drug development.
- Addressing synthesis and mechanism of action challenges is crucial for advancing these compounds.
- Further research can pave the way for effective natural product-derived antimalarials.

